The checklist was created to walk researchers through every operational step of using portable MRI, from creating protocols to prepping patients, ensuring patient safety, handling incidental findings, data privacy and more. 

Nina Kottler, MD, associate CMO for clinical AI at Radiology Partners, explains the movement toward greater regulation of artificial intelligence and the need to test for bias. 

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.

Melissa Davis, MD, vice chair of medical informatics and associate professor at Yale University’s Department of Radiology and Biomedical Imaging, shares her findings from research on private equity market penetration.

The bioresorbable agent is made from small irregularly shaped, dry gelatin particles designed for the embolization of hypervascular tumors and blood vessels. 

Diagnostic imaging leads the way in AI product approvals by a mile, accounting for more than 70% of all applications on the list. 

The new appropriate use criteria define 17 specific clinical scenarios, guiding providers on situations when amyloid or tau imaging are and are not appropriate.